eXoZymes (EXOZ) vs Instil Bio (TIL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Instil Bio (TIL) has outperformed eXoZymes (EXOZ) over the past year, losing 60.2% versus a loss of 81.8%. Instil Bio is the larger company by market cap ($35.5 million vs $27.4 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EXOZ | TIL |
|---|---|---|
| Share price | $2.91 | $5.23 |
| Market cap | $27.42M | $35.47M |
| 1-day change | -14.05% | -5.77% |
| YTD return | -73.35% | -52.45% |
| 1-year return | -81.84% | -60.20% |
| 5-year return | — | -98.72% |
| EPS (TTM) | $-1.16 | $-3.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $10.77M |
| Revenue growth (YoY) | — | +152.38% |
| Net income (latest FY) | $-9.16M | $-71.37M |
| Operating margin | — | -745.39% |
| Net margin | — | -662.75% |
| 52-week high | $16.16 | $12.92 |
| 52-week low | $2.81 | $5.14 |
| Distance from 52-week high | -82.02% | -59.51% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | — | +33.84% |
| Average volume | 10.14K | 42.02K |
| Shares outstanding | 9.44M | 6.78M |
| Employees | 32 | 17 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TIL has outperformed EXOZ by 21.6 percentage points over the past year.
About eXoZymes
EXOZ stock →eXoZymes, Inc. operates as a development stage biotechnology company.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 32 employees
About Instil Bio
TIL stock →Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 17 employees
EXOZ vs TIL FAQ
Which is bigger, eXoZymes or Instil Bio?
Instil Bio (TIL) is larger, with a market capitalization of $35.47M compared with $27.42M for eXoZymes (EXOZ).
Which stock has performed better over the past year, EXOZ or TIL?
TIL returned -60.20% over the past 12 months, compared with -81.84% for EXOZ (price return, excluding dividends). Past performance does not predict future results.
Are eXoZymes and Instil Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.